TMDX
TransMedics Group, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$89.98
+3.45%Forward multiples
Based on analyst estimates
- P/E forward
- 48.02x
- P/E 2026E
- 58.40x
- P/E 2027E
- 37.99x
- P/E 2028E
- 27.04x
- P/S forward
- 3.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- 20.36x
- PEG TTM
- —
- Price / book
- 6.02x
- Price / sales
- 4.67x
- Price / cash flow
- 21.38x
Enterprise value
- Enterprise value
- $3.5B
- EV / sales
- 5.26x
- EV / EBITDA
- 29.30x
- EV / EBIT
- 43.07x
- Market cap
- $3.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026